X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (96056) 96056
Newspaper Article (14016) 14016
Newsletter (1313) 1313
Book Chapter (842) 842
Magazine Article (728) 728
Government Document (602) 602
Dissertation (389) 389
Trade Publication Article (242) 242
Publication (158) 158
Web Resource (91) 91
Book / eBook (89) 89
Conference Proceeding (47) 47
Reference (44) 44
Book Review (30) 30
Streaming Video (6) 6
Paper (3) 3
Report (3) 3
Transcript (3) 3
Journal / eJournal (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (55112) 55112
male (50335) 50335
androgens (43880) 43880
animals (28260) 28260
female (27244) 27244
prostate cancer (23159) 23159
testosterone (19699) 19699
androgen receptor (14618) 14618
oncology (14167) 14167
endocrinology & metabolism (13434) 13434
middle aged (12676) 12676
adult (12404) 12404
aged (11066) 11066
rats (10278) 10278
cancer (9540) 9540
research (9405) 9405
receptors, androgen - metabolism (8424) 8424
mice (8215) 8215
prostatic neoplasms - pathology (8019) 8019
urology & nephrology (7875) 7875
expression (7613) 7613
androgen (7427) 7427
prostatic neoplasms - drug therapy (6983) 6983
men (6698) 6698
testosterone - blood (6636) 6636
hormones (6522) 6522
biochemistry & molecular biology (6401) 6401
receptors, androgen - genetics (6277) 6277
prostate (6192) 6192
androgen antagonists - therapeutic use (6018) 6018
androgens - metabolism (5978) 5978
analysis (5746) 5746
care and treatment (5503) 5503
estrogen (5500) 5500
metastasis (5459) 5459
prostatic neoplasms - metabolism (5158) 5158
cell line, tumor (5030) 5030
gene expression (4933) 4933
cell biology (4880) 4880
adolescent (4796) 4796
health aspects (4795) 4795
androgens - pharmacology (4629) 4629
risk factors (4537) 4537
proteins (4423) 4423
castration (4366) 4366
women (4329) 4329
aged, 80 and over (4080) 4080
apoptosis (4047) 4047
androgens - blood (4001) 4001
prostatic neoplasms - genetics (3921) 3921
physiological aspects (3835) 3835
testosterone - pharmacology (3817) 3817
cancer therapies (3773) 3773
pregnancy (3747) 3747
androgens - physiology (3714) 3714
growth (3711) 3711
therapy (3638) 3638
tumors (3595) 3595
immunohistochemistry (3591) 3591
treatment outcome (3560) 3560
cells (3449) 3449
carcinoma (3429) 3429
studies (3375) 3375
orchiectomy (3374) 3374
time factors (3137) 3137
gene-expression (3121) 3121
obstetrics & gynecology (3085) 3085
metabolism (3069) 3069
steroids (3058) 3058
neurosciences (3048) 3048
testosterone - metabolism (3029) 3029
medicine (3023) 3023
prognosis (2985) 2985
pharmacology & pharmacy (2963) 2963
mutation (2961) 2961
risk (2912) 2912
breast cancer (2877) 2877
genetic aspects (2842) 2842
estrogens (2836) 2836
estradiol (2835) 2835
urology (2830) 2830
reproductive biology (2768) 2768
signal transduction (2763) 2763
prostatic neoplasms - therapy (2758) 2758
patients (2756) 2756
chemotherapy (2716) 2716
androgens - therapeutic use (2704) 2704
radiotherapy (2665) 2665
hormone replacement therapy (2660) 2660
genes (2630) 2630
radical prostatectomy (2604) 2604
medical research (2592) 2592
clinical trials (2554) 2554
androgen deprivation therapy (2526) 2526
prostate-cancer (2510) 2510
prostate-specific antigen - blood (2474) 2474
child (2448) 2448
multidisciplinary sciences (2442) 2442
activation (2418) 2418
research article (2414) 2414
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (49) 49
Online Resources - Online (20) 20
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Gerstein Science - Theses (3) 3
University Archives - Archives (3) 3
UofT at Mississauga - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Cancelled Order (2) 2
Gerstein Science - Bindery (2) 2
Gerstein Science - Periodical Stacks (2) 2
Gerstein Science - Not Returned (1) 1
Gerstein Science - Searching (1) 1
New College (Ivey) - Stacks (1) 1
Royal Ontario Museum - Periodical Stacks (1) 1
Scarborough Hospital - General (1) 1
St. Michael's Hospital - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (107558) 107558
German (2023) 2023
French (1992) 1992
Japanese (1502) 1502
Russian (734) 734
Spanish (508) 508
Italian (474) 474
Chinese (441) 441
Polish (235) 235
Portuguese (220) 220
Czech (140) 140
Hungarian (107) 107
Korean (77) 77
Dutch (68) 68
Norwegian (51) 51
Bulgarian (47) 47
Danish (44) 44
Swedish (44) 44
Turkish (33) 33
Finnish (26) 26
Romanian (26) 26
Ukrainian (25) 25
Croatian (24) 24
Serbian (20) 20
Slovak (18) 18
Hebrew (13) 13
Persian (9) 9
Afrikaans (7) 7
Lithuanian (5) 5
Slovenian (3) 3
Arabic (2) 2
Hindi (2) 2
Urdu (2) 2
Welsh (2) 2
Armenian (1) 1
Belarusian (1) 1
Catalan (1) 1
Indonesian (1) 1
Thai (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of andrology, ISSN 0196-3635
Journal
Science (American Association for the Advancement of Science), ISSN 1095-9203, 2009, Volume 324, Issue 5928, pp. 787 - 790
Metastatic prostate cancer is treated with drugs that antagonize androgen action, but most patients progress to a more aggressive form of the disease called... 
COS cells | Androgens | Cell lines | Agonists | Oncology | Reports | Androgen antagonists | Prostate cancer | Heterologous transplantation | Tumors | Vehicles | NONSTEROIDAL ANTIANDROGENS | STRUCTURAL BASIS | AFFINITY | MULTIDISCIPLINARY SCIENCES | ANDROGEN-RECEPTOR | RESISTANCE | ANTAGONISM | LIGAND | MODEL | BICALUTAMIDE | Transcription, Genetic - drug effects | Nitriles - pharmacology | Phenylthiohydantoin - therapeutic use | Humans | Receptors, Androgen - metabolism | Biological Availability | Male | Antineoplastic Agents - therapeutic use | Tosyl Compounds - pharmacology | Antineoplastic Agents - metabolism | Cell Nucleus - metabolism | Receptors, Androgen - chemistry | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Prostatic Neoplasms - drug therapy | Androgen Antagonists - pharmacokinetics | Phenylthiohydantoin - pharmacology | Nitriles - metabolism | Prostatic Neoplasms - pathology | Androgen Antagonists - metabolism | Androgen Antagonists - pharmacology | Anilides - metabolism | DNA - metabolism | Phenylthiohydantoin - analogs & derivatives | Xenograft Model Antitumor Assays | Animals | Receptors, Androgen - genetics | Anilides - pharmacology | Tosyl Compounds - metabolism | Androgen Antagonists - therapeutic use | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Phenylthiohydantoin - metabolism | Drug Screening Assays, Antitumor | Phenylthiohydantoin - pharmacokinetics | Care and treatment | Antiandrogens | Dosage and administration | Drug therapy | Methods | Cancer | Chemotherapy | Pharmacology | Binding sites
Journal Article
Molecular and cellular endocrinology, ISSN 0303-7207, 2012, Volume 360, Issue 1-2, pp. 3 - 13
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 4, pp. 352 - 360
The addition of abiraterone, a drug that blocks endogenous androgen synthesis, to standard androgen-deprivation therapy in patients with newly diagnosed,... 
ANDROGEN-DEPRIVATION THERAPY | MEDICINE, GENERAL & INTERNAL | RECOMMENDATIONS | PLACEBO-CONTROLLED PHASE-3 | SURVIVAL ANALYSIS | CLINICAL-TRIALS | DOUBLE-BLIND | LEUPROLIDE ACETATE | DOCETAXEL | CHEMOTHERAPY | NEOADJUVANT | Prednisolone - adverse effects | Steroid 17-alpha-Hydroxylase - antagonists & inhibitors | Prostatic Neoplasms - radiotherapy | Prednisolone - administration & dosage | Prostatic Neoplasms - surgery | Humans | Middle Aged | Abiraterone Acetate - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Prostatic Neoplasms - mortality | Abiraterone Acetate - administration & dosage | Neoplasm Metastasis - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged, 80 and over | Androgen Antagonists - therapeutic use | Adult | Aged | Androgen Antagonists - administration & dosage | Androgen Antagonists - adverse effects | Prostatic Neoplasms - drug therapy | Androgen suppression therapy | Usage | Prednisone | Research | Prostate cancer | Medical research | Prostate-specific antigen | Clinical trials | Metastasis | Patients | Cancer therapies | Metastases | Androgens | Chemotherapy | Pain | Castration | Medical prognosis | Hypokalemia | Death | Prostate | Abiraterone Acetate/administration & dosage | Prednisolone/administration & dosage | Androgen Antagonists/administration & dosage | Medical and Health Sciences | Medicin och hälsovetenskap | Neoplasm Metastasis/drug therapy | Steroid 17-alpha-Hydroxylase/antagonists & inhibitors | Antineoplastic Combined Chemotherapy Protocols/adverse effects | Klinisk medicin | Clinical Medicine | Prostatic Neoplasms/drug therapy | Cancer and Oncology | Cancer och onkologi
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 4, pp. 338 - 351
Journal Article
by Yuan, X and Cai, C and Chen, S and Yu, Z and Balk, S P
Oncogene, ISSN 1476-5594, 2013, Volume 33, Issue 22, pp. 2815 - 2825
Journal Article